Karyopharm Therapeutics Inc.KPTINASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, modest growth trend.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-127.63M
Near historical average
Average (9y)
$-124.94M
Historical baseline
Range
High:$-73.78M
Low:$-191.03M
CAGR
+3.3%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $-127.63M | -37.6% |
| 2023 | $-92.72M | +38.0% |
| 2022 | $-149.67M | -32.7% |
| 2021 | $-112.83M | +29.6% |
| 2020 | $-160.38M | +16.0% |
| 2019 | $-191.03M | -18.3% |
| 2018 | $-161.48M | -118.9% |
| 2017 | $-73.78M | +12.6% |
| 2016 | $-84.46M | +11.5% |
| 2015 | $-95.44M | - |